We are live on ! Find out more
MTEM

Molecular Templates, Inc.

Delisted

MTEM was delisted on the 24th of December, 2024.

102 hedge funds and large institutions have $445M invested in Molecular Templates, Inc. in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more call options, than puts

Call options by funds: $1.52M | Put options by funds: $415K

63% more capital invested

Capital invested by funds: $273M → $445M (+$172M)

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

5% more funds holding

Funds holding: 97102 (+5)

6% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
102
Holders Change
+5
Holders Change %
+5.15%
% of All Funds
1.79%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
14
Increased
36
Reduced
34
Closed
9
Calls
$1.52M
Puts
$415K
Net Calls
+$1.11M
Net Calls Change
+$321K
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Bellevue Group
Switzerland
$103M +$20.3M +115,718 +27%
BlackRock
2
BlackRock
New York
$38.6M -$199K -1,133 -0.6%
BI
3
BVF Inc
California
$36.1M +$8.36M +47,683 +33%
PAMU
4
Pictet Asset Management (UK)
United Kingdom
$33.6M +$3.51M +20,000 +13%
Vanguard Group
5
Vanguard Group
Pennsylvania
$32.5M +$2.29M +13,032 +8%
CC
6
Caxton Corporation
New Jersey
$26.8M
FM
7
Frazier Management
Washington
$17.3M +$6.22M +35,476 +63%
WP
8
Woodline Partners
California
$14.5M +$7.34M +41,857 +121%
KCM
9
Kingdon Capital Management
New York
$12.1M +$2.34M +13,334 +26%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$11.9M +$11M +62,667 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$10.7M +$9.53M +54,375 +2,684%
Millennium Management
12
Millennium Management
New York
$9.04M +$3.15M +17,978 +60%
ECM
13
Endurant Capital Management
California
$8.95M +$329K +1,875 +4%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$7.88M +$4.62M +26,350 +173%
SAM
15
Sectoral Asset Management
Quebec, Canada
$7.78M +$4.58M +26,130 +175%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$7.12M +$864K +4,925 +15%
State Street
17
State Street
Massachusetts
$5.74M -$46.3K -264 -0.9%
Northern Trust
18
Northern Trust
Illinois
$4.64M -$269K -1,533 -6%
SW
19
SVB Wealth
Massachusetts
$4.35M +$525K +2,994 +15%
JP Morgan Chase
20
JP Morgan Chase
New York
$4.17M +$2.83M +16,154 +276%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$4.02M -$616K -3,513 -14%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$3.63M -$46.1K -263 -1%
Charles Schwab
23
Charles Schwab
California
$3.08M +$310K +1,769 +12%
AIIC
24
AJU IB Investment Company
South Korea
$2.58M
TCM
25
Tekla Capital Management
Massachusetts
$2.52M -$238K -1,360 -9%

MTEM Hedge Fund Activity: Q1 2021 in Review

102 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q1 2021, worth a combined $445M — up 63% from $273M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MTEM positions and 9 closed out — a net gain of 5 holders — while 36 added to existing stakes and 34 trimmed.

The largest buyer was Bellevue Group, adding an estimated $20.3M. The largest seller was Morgan Stanley, cutting an estimated $4.01M.

  • 102 institutional investors held Molecular Templates, Inc. (MTEM) as of Q1 2021, up from 97 in Q4 2020.
  • Funds reported $445M of Molecular Templates, Inc. stock for Q1 2021, up 63% quarter-over-quarter.
  • 14 funds opened new Molecular Templates, Inc. positions in Q1 2021 and 9 closed out, a net change of +5 holders.
  • The largest Molecular Templates, Inc. buyer in Q1 2021 was Bellevue Group, an estimated $20.3M added.
  • The largest Molecular Templates, Inc. seller in Q1 2021 was Morgan Stanley, an estimated $4.01M sold.

Based on aggregated 13F filings for Q1 2021.